Authors
Loading...
Analysis revealed psychoactive substances in Ecstasy tablets, suggesting toxicity risks from novel ingredient MDDM.
Byrska et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: